VARKI PAUL sold AVTX
May 6, 2026 · Form 4 insider transaction
VARKI PAUL sold 400 shares of Avalo Therapeutics, Inc. at $23.71 per share, a transaction worth $9.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$23.71
Total value
$9.5K
InsiderVARKI PAUL
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 6, 2026
Filing dateMay 7, 2026
Shares owned after3,634
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.